Abstract
The precise mechanisms by which many clinically useful immunorequlatory aqents produce immunologic dysfunction are not clear, even though many of their cytotoxic and mutagenic effects are well understood. Adenosine deaminase (ADA) deficiency and purine nucleoside Phosphorylase (PNP) deficiency are both inborn errors of purine metabolism characterized by severe immunodeficiency with the biochemical derangements in these diseases including the toxic accumulation of dATP or dGTP, respectively, (see Figure 1).1 Under the appropriate conditions, both the biochemcial changes and the selective lymphotoxicity observed in the ADA and PNP deficiency diseases can be reproduced in an in vitro cell culture system. A low concentration of deoxyadenosine in the presence of an ADA inhibitor leads to the accumulation of dATP and toxicity in cultured T lymphoblasts but not in B lymphoblasts, thus mimicking ADA deficiency disease.2 The addition of deoxyguanosine (50 μM) to culture medium leads to a selective increase in the level of dGTP and toxicity for T cells but not for B cells, analogous to changes observed in PNP deficiency disease.2 In the present study, we have used this lymphoblast tissue culture system to determine whether any of a selected group of immunoregulatory drugs were inhibitory to the growth of cultured T and B cells and, if so, to establish whether the toxicity could be attributed to interference with either ADA or PNP activity or related to an accumulation of dATP or dGTP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
B.S. Mitchell and W.N. Kelley, Purinogenic immunodeficiency disease: Clinical features and molecular mechanisms, Ann. Int. Med. 92: 826 (1980).
B.S. Mitchell, E. Mejias, P.E. Daddona and W.N. Kelley, Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleotides for T-cells, Proc. Natl. Acad. Sci. U.S.A. 75: 5011 (1978).
D.A. Carson, J. Kaye and J.E. Seegmiller, Metabolism and toxicity of 9-β-D-arabinofuranosyl adenine in human malignant T cells and B cells in culture, Adv. Exp. Med. Biol. 122B:299 (1979).
M.B. Van der Weyden, R.H. Buckley and W.N. Kelley, Molecular form of adenosine deaminase in severe combined immunodeficiency, Biochem. Biophys. Res. Commun. 57: 590 (1974).
I.H. Fox, C.M. Andres, E.W. Gelfand and D. Biggar, Purine nucleoside Phosphorylase deficiency: Altered kinetic properties of a mutant enzyme, Science 197: 1084 (1977).
I.S. Kazmers, P.E. Daddona, A.P. Dalke and W.N. Kelley, Effects of immunoregulatory agents on human T and B lymphoblasts, submitted for publication.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kazmers, I.S., Dalke, A.P., Daddona, P.E., Kelley, W.N. (1984). Sensitivity of Human T and B Lymphoblasts to Immunoregulatory Drugs. In: De Bruyn, C.H.M.M., Simmonds, H.A., Müller, M.M. (eds) Purine Metabolism in Man-IV. Advances in Experimental Medicine and Biology, vol 165. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0390-0_42
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0390-0_42
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0392-4
Online ISBN: 978-1-4757-0390-0
eBook Packages: Springer Book Archive